Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees
Open accessPublished version of a preprint
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
To the Editor—The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in places where the virus is uncontained poses a global threat from the perspective of public health and vaccine efficacy. Peng et al [1] recently reported on the increased transmissibility with the newly emerged Variant of Concern (VOC) (20C/S:452R and 20C/S:452R) with the L452R mutation in San Francisco. We report the immunological characteristics of a Variant under Investigation (VUI) B.1.617.1, playing a critical role in the current surge of coronavirus disease 2019 (COVID-19) in the western state of Maharashtra, India. Several SARS-CoV-2 variants—B.1.1.7, B.1.351, and B.1.1.28.1—have been reported in India during 2021 [2, 3]. We had sequenced 146 nasopharyngeal/oropharyngeal swabs of COVID-19 cases [4]. Among these, 15 sequences had a combination of L452R and E484Q mutations, which raised concern as both are found in the receptor-binding domain (RBD) of the spike protein. However, the combined effect of these mutations is still unknown.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.012 · Cited by 1,956
Neutralizing Activity of BNT162b2-Elicited Serum
Liu, Y., Liu, J., Xia, H., Zhang, X., Fontes-Garfias, C. R., Swanson, K. A., Cai, H., Sarkar, R., Chen, W., Cutler, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2102017 · Cited by 537
Ella, R., Vadrevu, K. M., Jogdand, H., Prasad, S., Reddy, S., Sarangi, V., Ganneru, B., Sapkal, G., Yadav, P., Abraham, P., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30942-7 · Cited by 424
Self-citationTchesnokova, V., Kulasekara, H., Larson, L., Bowers, V., Rechkina, E., Kisiela, D., Sledneva, Y., Choudhury, D., Maslova, I., Deng, K., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00921-21 · Cited by 217
Tchesnokova, V., Kulakesara, H., Larson, L., et al. (2021) · bioRxiv · doi:10.1101/2021.02.22.432189 · Cited by 154
Teng, S., Sobitan, A., Rhoades, R. E., Liu, D., & Tang, Q. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa233 · Cited by 125
Sapkal, G. N., Yadav, P. D., Ella, R., Deshpande, G. R., Sahay, R. R., Gupta, N., Vadrevu, K. M., Abraham, P., Panda, S., & Bhargava, B. (2021) · Journal of Travel Medicine · doi:10.1093/jtm/taab051 · Cited by 121
Self-citationFirst isolation of SARS-CoV-2 from clinical samples in India
Sarkale, P., Patil, S., Yadav, P. D., Nyayanit, D. A., Sapkal, G. N., Baradkar, S., Lakra, R., Shete-Aich, A., Prasad, S., Basu, A., et al. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1029_20 · Cited by 112
Self-citationNeutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
Deshpande, G. R., Sapkal, G. N., Tilekar, B. N., Yadav, P. D., Gurav, Y. K., Gaikwad, S., Kaushal, H., Deshpande, K., Kaduskar, O., Sarkale, P., et al. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_2382_20 · Cited by 77
Self-citationYadav, P. D., Nyayanit, D. A., Sahay, R. R., Sarkale, P., Pethani, J. D., Patil, S., Baradkar, S., Potdar, V. A., & Patil, D. Y. (2021) · Journal of Travel Medicine · doi:10.1093/jtm/taab009 · Cited by 45
Self-citation
Research works printed but not linked: 1
- Rambaut, Nat Microbiol
Cited by
Items 201–247 of 247
Zhao, S., Lou, J., Cao, L., Zheng, H., Chong, K. C., Chen, Z., Chan, R. W. Y., Zee, B. C.-Y., Chan, P. K. S., & Wang, M. H. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06729-w · Cited by 2
Safety, efficacy, and immunogenicity of COVAXIN: A review
Dar, M. A., Chauhan, P., Kumar, P., Chauhan, R., Murti, K., Charan, J., Ravichandiran, V., & Dhingra, S. (2021) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2021.1101103 · Cited by 2
CRISPR-based Approaches for the Point-of-Care Diagnosis of COVID19
Uzay, İ. A., & Dinçer, P. (2022) · Acta Medica · doi:10.32552/2022.actamedica.626 · Cited by 2
A Review on Variant of Concern (Delta Variant of COVID 19)
Jangam, K. K., Vikhe, D. N., Jadhav, R. S., & Shinde, G. S. (2022) · Asian Journal of Research in Pharmaceutical Sciences · doi:10.52711/2231-5659.2022.00025 · Cited by 2
Zuo, P., Zuo, L., Li, Z., & Li, L. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002856 · Cited by 2
Infectivity and antigenicity of SARS-CoV-2 B.1.617 variantsPreprint
Wang, Y., Zhang, L., Li, Q., Wu, J., Yu, Y., Zhang, Y., Nie, J., Liang, Z., Cui, Z., Liu, S., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-596463/v1 · Cited by 2
Immunity Escape of SARS-CoV-2 Variants: Omicron Leads the WayPreprint
Dhingra, R., Sharma, A., Balda, S., Billa, A., Sah, S. N., Capalash, N., & Sharma, P. (2022) · Preprints.org · doi:10.20944/preprints202203.0376.v1 · Cited by 1
Vaccine-induced immune responses against SARS-CoV-2 infections
Garg, M. K., Maralakunte, M., Kumar, Y., Bhujade, H., Sehgal, I. P., Suri, V., & Garg, S. (2021) · Exploration of Immunology · doi:10.37349/ei.2021.00024 · Cited by 2
CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy
Billmeier, A., Khinvasara, K., Lang, F., Mohr, J., Reidenbach, D., Schork, M., Yildiz, I., & Diken, M. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.2024416 · Cited by 1
Adenovirus-Based Single-Dose Vaccines for SARS-CoV-2: A Review
Chavda, V. P., Mehta, A. A., Zafar, H., Raza, F., Paiva‐Santos, A. C., Balar, P. C., Apostolopoulos, V., & Vora, L. K. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl25094 · Cited by 2
Comparative Analysis of B.1.617.2 (Delta) Variant of SARS-CoV-2
Shahanshah, M. F. H., JAİN, S., Sharma, B., Grewall, A., & Swami, S. (2022) · Journal of Microbiology and Infectious Diseases · doi:10.5799/jmid.1086226 · Cited by 3
COVID -19: From the Molecular Mechanisms to Treatment.
Habibzadeh, S., Hashemzadeh, N., Baradaran, H., Soofiyani, S. R., Jadideslam, G., & Pahlavan, Y. (2022) · PubMed Central · Cited by 1
Madishetti, V. V., Reddy, S., Kalagara, S., Garg, A., Enaganti, S., & Hussain, S. (2023) · The EuroBiotech Journal · doi:10.2478/ebtj-2023-0009 · Cited by 1
Variantes de SARS CoV-2: Prevalencia y complicaciones en la población adulta
Reyes-Baque, J. M., Palma-Anchundia, E. D., & Quijije-Barcia, J. L. (2024) · MQRInvestigar · doi:10.56048/mqr20225.8.1.2024.3040-3058
COVID-19: sudden and dramatic upsurge in the number of cases in India
Barot, K. S., Naik, S. H., Patel, M. H., Mankad, S. P., Patel, A. A., Pandya, P., Patel, V., & Nimbalkar, S. M. (2021) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20213047
Malviya, J., Parmar, A., Parmar, L., Khan, R., Roy, R., Kanade, S., Giri, P., & Rathore, B. (2021) · American Journal of Biomedical and Life Sciences · doi:10.11648/j.ajbls.20210904.16 · Cited by 1
Bioinformatic and MD Analysis of N501Y SARS-CoV-2 (UK) Variant
Jukič, M., Kralj, S., Nikitina, N., & Bren, U. (2021) · IFIP advances in information and communication technology · doi:10.1007/978-3-030-86582-5_1 · Cited by 1
COVID flood, can vaccines withstand?
Elghannam, R., & Abo-Elmagd, M. (2021) · Medicine Updates · doi:10.21608/muj.2021.94130.1058 · Cited by 1
Jati, S., Basalingappa, K. M., Geethanjali, B., Parthiban, R., Rajashekara, S., & Gopenath, T. S. (2021) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.15.4.61 · Cited by 1
Listenberger, L. L., Joiner, C. M., & Terrell, C. R. (2022) · CourseSource · doi:10.24918/cs.2022.5
Current strategies and future perspectives in COVID-19 therapy
Aravind, S. R., Mathew, K. A., Madathil, B. K., Mini, S., & John, A. P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89972-7.00011-8 · Cited by 1
Genomics and epidemiology of SARS-CoV-2 lineage
Sukegawa, S., & Takeuchi, H. (2021) · Uirusu · doi:10.2222/jsv.71.19 · Cited by 1
The Conflict between Emerging SARS-Cov-2 Variants and the Potential Immune Response with Vaccination
Alvez, F. L. (2021) · Annals of Immunology & Immunotherapy · doi:10.23880/aii-16000148
Severe Acute Respiratory Syndrome Coronaviruses-2 (SARS-CoV-2)
Al‐Tawfiq, J. A., & Memish, Z. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-27164-9_50 · Cited by 1
Isolation and characterization of SARS-CoV-2 VOC, 20H/501Y.V2, from UAE travelersPreprint
Yadav, P. D., Sarkale, P., Razdan, A., Gupta, N., Nyayanit, D. A., Sahay, R. R., Potdar, V. A., Patil, D. Y., Baradkar, S., Kumar, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.14.443968 · Cited by 1
Self-citationKumar, S., Saxena, S., Atri, M., & Chamola, S. (2021) · medRxiv · doi:10.1101/2021.05.28.21257967 · Cited by 2
The Origins of the Second Wave of COVID-19 in India - a Model-based investigationPreprint
Shayak, B., & Sharma, M. (2021) · SocArXiv (OSF Preprints) · doi:10.31235/osf.io/ce9kx · Cited by 1
Systems immune profiling of variant-specific vaccination against SARS-CoV-2Preprint
Peng, L., Park, J. J.-Y., Fang, Z., Zhou, X., Dong, M. B., Xiong, Q., Lin, C., & Chen, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.02.471028 · Cited by 1
IMPACT OF VACCINATION ON COVID INFECTION IN HEALTH CARE WORKERS IN WESTERN ZONE OF INDIAN RAILWAYS
Anand, C., Rehman, H., Kumar, K. K., Prakash, B., Kumar, S., Malviya, A. K., Chakraborty, M., Srivastava, A., Rawat, J. P., Patil, Y. V., et al. (2021) · PARIPEX-INDIAN JOURNAL OF RESEARCH · doi:10.36106/paripex/6501060
Singh, P., Ujjainiya, R., Prakash, S., Naushin, S., Sardana, V., Bhatheja, N., Singh, A. P., Barman, J., Kumar, K., Khan, R., et al. (2021) · medRxiv · doi:10.1101/2021.12.16.21267889
Self-citationPerez, J. C. (2021) · Preprints.org · doi:10.20944/preprints202104.0689.v2
Controlling COVID-19 and Preparing forFuture Pandemics
Barry, D. M., & Kanematsu, H. (2022) · Springer eBooks · doi:10.1007/978-981-19-1356-3_11
Sahay, R. R., Shete, A. M., Sapkal, G. N., Deshpande, G. R., Shah, A. D., Kumar, S., Abraham, P., & Yadav, P. D. (2022) · International Journal of Microbiology Research · doi:10.4103/ijmr.ijmr_1390_21
Self-citationApplication and Historical Aspects of Vaccine Development for Human Healthcare
Malviya, J., Giri, P., Rathore, B., Suryawanshi, R., Jain, A., Chincholikar, P., & Koshy, D. M. (2022) · Research Journal of Life Sciences Bioinformatics Pharmaceutical and Chemical Sciences · doi:10.26479/2022.0801.02
Severe Acute Respiratory Syndrome Coronaviruses-2 (SARS-CoV-2)
Al‐Tawfiq, J. A., & Memish, Z. A. (2023) · Springer eBooks · doi:10.1007/978-3-030-85877-3_50-1
Wallis, R. S., Srivastava, A. K., Wack, A., & Knirsch, C. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87539-4.00003-8
Tewari, A., & Kumar, R. (2023) · Microbes Infection and Chemotherapy · doi:10.54034/mic.e1808
Sarvmeili, J. (2022) · مجله دانشگاه علوم پزشکی اراک · doi:10.32598/jams.25.3.6932.1
Ramakrishnan, J., Chinnamadhu, A., Suresh, S., & Kumaradhas, P. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30432
Nema, V., Jadhav, S., Waghmode, R. B., Potdar, V. A., & Choudhary, M. L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.13.593815
Shatnawi, S., Gunasekara, S., Bashor, L., Selvan, M. T., Nehring, M., Cowan, S. R., Ritchey, J. W., VandeWoude, S., Taylor, B., Miller, C., et al. (2024) · Microorganisms · doi:10.3390/microorganisms12071289
SARS-CoV-2 Mutations and Their Impacts on Virulence and Transmissibility of The Virus
Bahman, S., Farajnia, S., Alizadeh, E., Charoudeh, H. N., Hosseini, M. K., & Naghili, B. (2024) · ImmunoAnalysis · doi:10.34172/ia.4070
Development and Validation of Microbiology and Parasitology Laboratory Manual for Science Education
Beltran, K. A. (2025) · Integrated Science Education Journal · doi:10.37251/isej.v6i2.1543 · Cited by 15
Ghalamghash, R. (2025) · Preprints.org · doi:10.20944/preprints202506.0418.v1
Kandeel, A., Moatasim, Y., Fahim, M., BahaaEldin, H., El‐Shesheny, R., Roshdy, W. H., Kamel, M. N., Shawky, S., Gomaa, M. R., Naguib, A. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26611478
COVID-19 vaccine-elicited immune mediators and their contribution to protective immunity
Mishra, A., Mallik, S., Chatterjee, S., Naser, S. M., & Mukhopadhyay, S. (2026) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20260725
Metadata
- Authors
- Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K.
- Affiliations
- ICMR-National Institute of Virology (IN)
- Bharat Biotech (India) (IN)
- Indian Council of Medical Research (IN)
- Corresponding author
- Yadav, Pragya D
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-05-07
- Volume
- 74
- Issue
- 2
- Pages
- 366-368
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W3159365602
- Cited by
- 251
- References
- 14
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 10 · 2023: 26 · 2022: 76 · 2021: 133
- FWCI
- 19.38
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- Clinical Infectious Diseases (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Indian Council of Medical Research
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Keywords
- SARS-CoV-2, Omicron variant, L452R mutation, receptor binding domain, Maharashtra, COVID-19 pandemic, spike protein mutations
- MeSH terms
- Antibodies, Viral, Humans, Neutralization Tests, Antibodies, Neutralizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.